Respuesta a: “Comentarios acerca del artículo “Tamización primaria con prueba ADN-VPH en mujeres menores de 30 años: evaluación de tecnología sanitaria””

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray. Global Cancer Observatory: Cancer Today [Internet]. Lyon, France: International Agency for Research on Cancer; 2020. Disponible en: https://gco.iarc.fr/today

Peirson, L., Fitzpatrick-Lewis, D., Ciliska, D. et al. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2(35). https://doi.org/10.1186/2046-4053-2-35

Ronco, G., Dillner, J., Elfstrom, K. M., Tunesi, S., Snijders, P. J., Arbyn, M. et al.Efficacy of HPV-based screening for prevention of invasive cervical cancer: followup of four European randomised controlled trials. Lancet. 2014;383, 524–532. https://doi.org/10.1016/S0140-6736(13)62218-7

Hashim D, Engesæter B, Baadstrand Skare G, Castle PE, Bjørge T, Tropé A, Nygård M. Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. Br J Cancer. 2020 May;122(11):1715-1723. https://doi.org/10.1038/s41416-020-0790-1

Gupta R, Sharda A, Kumar D, Fulzele R, Dwivedi R, Gupta S. Cervical Cancer Screening: Is the Age Group 30-65 Years Optimum for Screening in Low-Resource Settings? J Obstet Gynaecol India. 2021 Oct;71(5):530-536. https://doi.org/10.1007/s13224-021-01479-w

Sefuthi T, Nkonki L. A systematic review of economic evaluations of cervical cancer screening methods. Syst Rev. 2022 Aug 9;11(1):162. https://doi.org/10.1186/s13643-022-02017-z

Fogelberg S, Clements MS, Pedersen K, Sy S, Sparén P, Kim JJ, Burger EA. Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden. PLoS One. 2020 Sep 30;15(9):e0239611. https://doi.org/10.1371/journal.pone.0239611

Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, Byamugisha JK, Kim JJ, Bryan S, Ogilvie GS. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review. Int J Cancer. 2017 Aug 1;141(3):437-446. https://doi.org/10.1002/ijc.30695

Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua. BMJ Open. 2017 Jun 15;7(6):e015048. https://doi.org/10.1136/bmjopen-2016-015048

Chao YS, Clark M, Carson E, Weeks L, Moulton K, McFaul S, McLauchlin CM, Tsoi B, Majid U, Kandasamy S, Arora N, Vanstone M, Reid L, Krahn T, Kaluzny K, Farrah K, Ford C. HPV Testing for Primary Cervical Cancer Screening: A Health Technology Assessment [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar.

Mezei AK, Pedersen HN, Sy S, Regan C, Mitchell-Foster SM, Byamugisha J, Sekikubo M, Armstrong H, Rawat A, Singer J, Ogilvie GS, Kim JJ, Campos NG. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial. BMJ Open. 2018 Jun 12;8(6):e020484. https://doi.org/10.1136/bmjopen-2017-020484